Full Press Release Details
Regeneron and Sanofi Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma.
REGN
Regeneron and Sanofi Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma
Key Takeaway: Regeneron and Sanofi Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma